StockData
Tilray Brands, Inc. logo

Tilray Brands, Inc. (TLRY) stock

TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 11/3086% below fair value
$2.43−0.06 (-2.41%)

Close on Nov 13, 2026Market cap $359.12MP/E –Yield –

Tilray Brands total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Tilray Brands's total debt was $126.73M at Aug 31, 2026. For fiscal 2026 it was $129.20M, up 1699.2% from the year before. The highest annual figure on record is $203.83M in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2026May 31, 2026$129.20M+1699.2%
FY2025May 31, 2025$7.18M-60.2%
FY2024May 31, 2024$18.03M-22.9%
FY2023May 31, 2023$23.38M-88.5%
FY2022May 31, 2022$203.83M+2061.0%
FY2017Dec 31, 2017$9.43M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$126.73M+1448.4%
Q4 FY2026CQ2 2026May 31, 2026$129.20M+1699.2%
Q3 FY2026CQ1 2026Feb 28, 2026$8.83M-50.2%
Q2 FY2026CQ4 2025Nov 30, 2025$8.57M-52.8%
Q1 FY2026CQ3 2025Aug 31, 2025$8.19M-54.6%
Q4 FY2025CQ2 2025May 31, 2025$7.18M-52.2%
Q2 FY2025CQ4 2024Nov 30, 2024$17.75M-12.0%
Q1 FY2025CQ3 2024Aug 31, 2024$18.13M+24.3%
Q4 FY2024CQ2 2024May 31, 2024$18.03M-22.9%
Q3 FY2024CQ1 2024Feb 29, 2024$15.03M-17.1%
Q2 FY2024CQ4 2023Nov 30, 2023$20.18M+31.9%
Q1 FY2024CQ3 2023Aug 31, 2023$14.59M-82.3%
Q4 FY2023CQ2 2023May 31, 2023$23.38M-88.5%
Q3 FY2023CQ1 2023Feb 28, 2023$18.13M-91.3%
Q2 FY2023CQ4 2022Nov 30, 2022$15.30M-92.0%
Q1 FY2023CQ3 2022Aug 31, 2022$82.38M-59.8%
Q4 FY2022CQ2 2022May 31, 2022$203.83M+2080.4%
Q3 FY2022CQ1 2022Feb 28, 2022$208.88M+2188.4%
Q2 FY2022CQ4 2021Nov 30, 2021$192.07M+1936.3%
Q1 FY2022CQ3 2021Aug 31, 2021$204.95M–
Q3 FY2018CQ3 2018Sep 30, 2018$9.35M–
Q2 FY2018CQ2 2018Jun 30, 2018$9.13M–
Q4 FY2017CQ4 2017Dec 31, 2017$9.43M–

More Tilray Brands figures

See a number that looks wrong?